CURRENT VIEWS OF THE GLEASON GRADING SYSTEM

被引:0
|
作者
Gorban, N. A. [1 ]
Kudaibergenova, A. G. [2 ]
机构
[1] Russian Acad Med Sci, Med Radiol Res Ctr, Obninsk, Russia
[2] Fed Agcy High Technol Med Care, Russian Res Ctr, St Petersburg, Russia
来源
ONKOUROLOGIYA | 2010年 / 6卷 / 01期
关键词
Gleason scale gradation; criteria; differentiation; malignant component; malignancy grade;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The authors provide the proceedings of the 2005 First International Society of Urological Pathology Consensus Conference and the basic provisions that differ the modified Gleason grading system from its original interpretation. In particular, we should do away with Gleason grade 1 (or 1 + 1 = 2) while assessing the needle biopsy specimens. Contrary to the recommendations by Gleason himself, the conference decided to apply stringent criteria for using Gleason grades 3 and 4. This is due to the fact that these grades are of special prognostic value so it is important to have clear criteria in defining each Gleason grade. Notions, such as secondary and tertiary Gleason patterns, are considered; detailed recommendations are given on the lesion extent sufficient to diagnose these components.
引用
收藏
页码:69 / 75
页数:8
相关论文
共 50 条
  • [41] New Gleason grading system: Statement from the Editors of six journals
    Zietman, Anthony
    Smith, Joseph
    Klein, Eric
    Droller, Michael J.
    Dasgupta, Prokar
    Catto, James
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 253 - 253
  • [42] Implications of the International Society of Urological Pathology Modified Gleason Grading System
    Egevad, Lars
    Mazzucchelli, Roberta
    Montironi, Rodolfo
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (04) : 426 - 434
  • [43] New Gleason grading system: Statement from the editors of 6 journals
    Egevad, Lars
    Samaratunga, Hemamali
    Srigley, John R.
    Delahunt, Brett
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 479 - 480
  • [44] Relationship between microRNA expression and Gleason grading system in prostate cancer
    Tsuchiyama, Katsuki
    Ito, Hideaki
    Taga, Minekatsu
    Oshinoya, Konosuke
    Nagano, Kenichi
    Yokoyama, Osamu
    Itoh, Hiroshi
    CANCER RESEARCH, 2012, 72
  • [45] A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
    Epstein, Jonathan I.
    Zelefsky, Michael J.
    Sjoberg, Daniel D.
    Nelson, Joel B.
    Egevad, Lars
    Magi-Galluzzi, Cristina
    Vickers, Andrew J.
    Parwani, Anil V.
    Reuter, Victor E.
    Fine, Samson W.
    Eastham, James A.
    Wiklund, Peter
    Han, Misop
    Reddy, Chandana A.
    Ciezki, Jay P.
    Nyberg, Tommy
    Klein, Eric A.
    EUROPEAN UROLOGY, 2016, 69 (03) : 428 - 435
  • [46] Prostate Cancer: Update on Gleason Grading
    van Leenders, A.
    JOURNAL OF PATHOLOGY, 2018, 246 : S10 - S10
  • [47] Gleason grading: past, present and future
    Delahunt, Brett
    Miller, Rose J.
    Srigley, John R.
    Evans, Andrew J.
    Samaratunga, Hemamali
    HISTOPATHOLOGY, 2012, 60 (01) : 75 - 86
  • [48] Gleason grading: Diagnostic criteria and clinical implications [Gleason-grading: Diagnostische kriterien und klinische bedeutung]
    Bonkhoff H.
    Der Pathologe, 2005, 26 (6): : 422 - 432
  • [49] THE "NEW" ISUP MODIFIED GLEASON GRADING SYSTEM AND ICCR DATASETS FOR PROSTATE CANCER
    Kench, J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 30 - 30
  • [50] RELIABILITY OF GLEASON GRADING SYSTEM IN COMPARING PROSTATE BIOPSIES WITH TOTAL PROSTATECTOMY SPECIMENS
    BABAIAN, RJ
    GRUNOW, WA
    UROLOGY, 1985, 25 (06) : 564 - 567